To establish a protocol for a multicentre randomized controlled trial evaluating treatments for gastroesophageal reflux disease in infants.
Design a multicentre randomized controlled trial
Recruit infants diagnosed with gastroesophageal reflux disease
Implement various treatment protocols across centers
Use standardized assessments and data collection methods
Anticipated outcomes include efficacy of treatments on reflux symptoms in infants
Assessment of safety and tolerability of interventions
Expectation to contribute to guidelines for managing reflux in infants
Abstract
eu EU-CT: 2022-502770-16-00. Registered on November 4, 2024.
问 AI
Like
Bookmark
Share
View Full Paper
问 AI
Like
Bookmark
Share
View Full Paper
Infant Reflux Trial: study protocol for a multicentre randomized controlled trial on the treatment of gastroesophageal reflux disease in infants | Synapse